Literature DB >> 28073861

The quest for a successful cell-based therapeutic approach for heart failure.

Ana Marie Landin1, Joshua M Hare1,2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28073861      PMCID: PMC6515521          DOI: 10.1093/eurheartj/ehw626

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Authors:  Atta Behfar; Satsuki Yamada; Ruben Crespo-Diaz; Jonathan J Nesbitt; Lois A Rowe; Carmen Perez-Terzic; Vinciane Gaussin; Christian Homsy; Jozef Bartunek; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

Review 3.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

4.  Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.

Authors:  Vasileios Karantalis; Viky Y Suncion-Loescher; Luiza Bagno; Samuel Golpanian; Ariel Wolf; Cristina Sanina; Courtney Premer; Anthony J Kanelidis; Frederic McCall; Bo Wang; Wayne Balkan; Jose Rodriguez; Marcos Rosado; Azorides Morales; Konstantinos Hatzistergos; Makoto Natsumeda; Irene Margitich; Ivonne Hernandez Schulman; Samirah A Gomes; Muzammil Mushtaq; Darcy L DiFede; Joel E Fishman; Pradip Pattany; Juan Pablo Zambrano; Alan W Heldman; Joshua M Hare
Journal:  J Am Coll Cardiol       Date:  2015-11-03       Impact factor: 24.094

Review 5.  The war against heart failure: the Lancet lecture.

Authors:  Eugene Braunwald
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321

6.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

7.  Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

Authors:  Jozef Bartunek; Atta Behfar; Dariouch Dolatabadi; Marc Vanderheyden; Miodrag Ostojic; Jo Dens; Badih El Nakadi; Marko Banovic; Branko Beleslin; Mathias Vrolix; Victor Legrand; Christian Vrints; Jean Louis Vanoverschelde; Ruben Crespo-Diaz; Christian Homsy; Michal Tendera; Scott Waldman; William Wijns; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

8.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Authors:  Joshua M Hare; Joel E Fishman; Gary Gerstenblith; Darcy L DiFede Velazquez; Juan P Zambrano; Viky Y Suncion; Melissa Tracy; Eduard Ghersin; Peter V Johnston; Jeffrey A Brinker; Elayne Breton; Janice Davis-Sproul; Ivonne H Schulman; John Byrnes; Adam M Mendizabal; Maureen H Lowery; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Phillip Ruiz; Alexandra Amador; Jose Da Silva; Ian K McNiece; Alan W Heldman; Richard George; Albert Lardo
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

9.  Myocardial infarction and intramyocardial injection models in swine.

Authors:  Frederic C McCall; Kartik S Telukuntla; Vasileios Karantalis; Viky Y Suncion; Alan W Heldman; Muzammil Mushtaq; Adam R Williams; Joshua M Hare
Journal:  Nat Protoc       Date:  2012-07-12       Impact factor: 13.491

10.  Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Authors:  Alan W Heldman; Darcy L DiFede; Joel E Fishman; Juan P Zambrano; Barry H Trachtenberg; Vasileios Karantalis; Muzammil Mushtaq; Adam R Williams; Viky Y Suncion; Ian K McNiece; Eduard Ghersin; Victor Soto; Gustavo Lopera; Roberto Miki; Howard Willens; Robert Hendel; Raul Mitrani; Pradip Pattany; Gary Feigenbaum; Behzad Oskouei; John Byrnes; Maureen H Lowery; Julio Sierra; Mariesty V Pujol; Cindy Delgado; Phillip J Gonzalez; Jose E Rodriguez; Luiza Lima Bagno; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Jose da Silva; Erica Anderson; Richard Schwarz; Adam Mendizabal; Joshua M Hare
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

View more
  4 in total

1.  Short-term hypoxia improves early cardiac progenitor cell function in vitro.

Authors:  Ivan Hernandez; Jonathan M Baio; Eric Tsay; Aida F Martinez; Tania I Fuentes; Leonard L Bailey; Nahidh W Hasaniya; Mary Kearns-Jonker
Journal:  Am J Stem Cells       Date:  2018-02-01

2.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

3.  Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischaemic hindlimb repair via exosome/miR-24/Bim pathway.

Authors:  Yuqing Zhang; Yanli Wang; Lianbo Shao; Xiangbin Pan; Chun Liang; Bin Liu; Yu Zhang; Wenping Xie; Bing Yan; Feng Liu; Xi-Yong Yu; Yangxin Li
Journal:  J Cell Mol Med       Date:  2019-11-15       Impact factor: 5.310

4.  Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy.

Authors:  Satsuki Yamada; D Kent Arrell; Christian S Rosenow; Jozef Bartunek; Atta Behfar; Andre Terzic
Journal:  Stem Cells Transl Med       Date:  2019-08-02       Impact factor: 6.940

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.